A missense mutation (e.g., R172H) in the p53 gene is known to result in a loss of its tumor-suppressive function, in a dominant negative manner, by inhibiting the function of the remaining wild-type (WT) p53 allele [48]. This evidence concerns the gene TP53 and neoplasm.